Condition

Acute Promyelocytic Leukemia clinical trials and research

• 2Clinical trials
• 14Countries

All recruiting trials (2)

• QTX-2101 (oral arsenic) plus ATRA for adults with low- or intermediate-risk APL

  This Phase 3 trial tests whether an oral arsenic capsule (QTX-2101) combined with ATRA works well and is safe for adults aged 18–70 with newly diagnosed low- or intermediate-risk acute promyelocytic leukemia.

  Recruiting at 36 sites Phase 3 Quetzal Therapeutics · Birmingham, Alabama and 35 other locations · NCT07504458

• Treatment for Children and Adolescents with Acute Promyelocytic Leukemia

  This study is testing a new treatment for children and teenagers with acute promyelocytic leukemia that uses a combination of medications instead of traditional chemotherapy to see if it works better and is safer.

  Recruiting at 12 sites Phase 2 Associazione Italiana Ematologia Oncologia Pediatrica · Brussels and 30 other locations · NCT04793919

Related topics

Quick answers

How many Acute Promyelocytic Leukemia clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 14 countries. The most sites are in France (2 trials), Italy (2 trials), Spain (2 trials), Belgium (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →